Growth Metrics

Pacific Biosciences Of California (PACB) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 98.06%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.06%
Dec 31, 2025 -1,802.70%
Sep 30, 2025 37.42%
Jun 30, 2025 75.81%
Mar 31, 2025 -445.01%
Dec 31, 2024 102.89%
Sep 30, 2024 9.19%
Jun 30, 2024 -148.19%
Mar 31, 2024 11.18%
Dec 31, 2023 2.80%
Sep 30, 2023 13.12%
Jun 30, 2023 2.19%
Mar 31, 2023 -8.00%
Dec 31, 2022 -21.72%
Jun 30, 2022 -73.45%
Mar 31, 2022 -129.58%
Dec 31, 2021 -192.52%
Jun 30, 2021 -74.98%
Mar 31, 2021 -7.65%
Dec 31, 2020 502.98%
Sep 30, 2020 17.62%
Jun 30, 2020 5.99%
Mar 31, 2020 -7.21%
Dec 31, 2019 40.50%
Sep 30, 2019 -13.81%
Jun 30, 2019 -12.00%
Mar 31, 2019 -25.39%
Dec 31, 2018 -47.74%
Sep 30, 2018 -13.89%
Jun 30, 2018 11.38%
Mar 31, 2018 -1.63%
Dec 31, 2017 -13.04%
Sep 30, 2017 -26.46%
Jun 30, 2017 -33.65%
Mar 31, 2017 -24.78%
Dec 31, 2016 -919.78%
Sep 30, 2016 -1,037.32%
Jun 30, 2016 -56.26%
Mar 31, 2016 3.40%
Dec 31, 2015 90.14%
Sep 30, 2015 120.52%
Jun 30, 2015 36.47%
Mar 31, 2015 -5.78%
Dec 31, 2014 -5.21%
Sep 30, 2014 55.73%
Jun 30, 2014 8.06%
Mar 31, 2014 9.99%
Dec 31, 2013 18.68%
Sep 30, 2013 8.95%
Jun 30, 2013 8.64%
Mar 31, 2013 23.54%
Dec 31, 2012 4.09%
Sep 30, 2012 23.07%
Jun 30, 2012 0.17%
Mar 31, 2012 21.33%
Dec 31, 2011 37.99%
Sep 30, 2011 27.67%
Jun 30, 2011 30.64%